{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:12:30Z","timestamp":1791130350266,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.euroneuro.2012.05.004","type":"journal-article","created":{"date-parts":[[2012,6,15]],"date-time":"2012-06-15T23:15:14Z","timestamp":1339802114000},"page":"212-223","source":"Crossref","is-referenced-by-count":59,"title":["Chronic use of benzodiazepines and latent cognitive decline in the elderly: Results from the Three-city study"],"prefix":"10.1016","volume":"23","author":[{"given":"Thibault","family":"Mura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Proust-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasnime","family":"Akbaraly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Amieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Tzourio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Chevassus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Picot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Jacqumin-Gadda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Berr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.euroneuro.2012.05.004_bib1","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0887-6177(03)00096-9","article-title":"Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis","volume":"19","author":"Barker","year":"2004","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.euroneuro.2012.05.004_bib2","unstructured":"Benton, A., 1965. Manuel pour l'application du test de r\u00e9tention visuelle. Applications cliniques et exp\u00e9rimentales (in French), Centre de Psychologie appliqu\u00e9e. Paris, France."},{"issue":"12","key":"10.1016\/j.euroneuro.2012.05.004_bib3","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/gps.1811","article-title":"The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent?","volume":"22","author":"Bierman","year":"2007","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2012.05.004_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1381612023396654","article-title":"Cognitive and sedative effects of benzodiazepine use","volume":"8","author":"Buffett-Jerrott","year":"2002","journal-title":"Curr. Pharm. Des."},{"issue":"3","key":"10.1016\/j.euroneuro.2012.05.004_bib101","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1017\/S1355617703930074","article-title":"The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals","volume":"9","author":"Collie","year":"2003","journal-title":"J. Int. Neuropsychol. Soc."},{"issue":"1","key":"10.1016\/j.euroneuro.2012.05.004_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/00002512-199812010-00005","article-title":"Epidemiology of medication-related falls and fractures in the elderly","volume":"12","author":"Cumming","year":"1998","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.euroneuro.2012.05.004_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02316856","article-title":"Benzodiazepines, memory and mood: a review","volume":"105","author":"Curran","year":"1991","journal-title":"Psychopharmacology (Berlin)"},{"issue":"5","key":"10.1016\/j.euroneuro.2012.05.004_bib7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/(SICI)1099-1166(199705)12:5<567::AID-GPS552>3.0.CO;2-V","article-title":"Psychotropic drug use and cognitive decline among older men and women","volume":"12","author":"Dealberto","year":"1997","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2012.05.004_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00002093-199803000-00002","article-title":"Benzodiazepines may have protective effects against Alzheimer disease","volume":"12","author":"Fastbom","year":"1998","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"3","key":"10.1016\/j.euroneuro.2012.05.004_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.euroneuro.2012.05.004_bib10","first-page":"2","article-title":"Prescribing of minor tranquilizaers","author":"Food and Drug Administration","year":"1980","journal-title":"FDA Drug Bull."},{"key":"10.1016\/j.euroneuro.2012.05.004_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S0767399X00001590","article-title":"La version fran\u00e7aise de l'\u00e9chelle CES-D (Center for Epidemiologic Studies Depression Scale)","volume":"4","author":"F\u00fchrer","year":"1989","journal-title":"Psychiatr. Psychobiol."},{"issue":"11\u201312","key":"10.1016\/j.euroneuro.2012.05.004_bib12","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/(SICI)1097-0258(20000615\/30)19:11\/12<1421::AID-SIM434>3.0.CO;2-P","article-title":"Measuring cognitive change in a cohort of patients with Alzheimer's disease","volume":"19","author":"Galasko","year":"2000","journal-title":"Stat. Med."},{"issue":"6","key":"10.1016\/j.euroneuro.2012.05.004_bib13","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0009-9236(98)90059-5","article-title":"Benzodiazepine use and cognitive function among community-dwelling elderly","volume":"64","author":"Hanlon","year":"1998","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2012.05.004_bib14","unstructured":"Haute Autorit\u00e9 de Sant\u00e9, 2007. Modalit\u00e9s d'arr\u00eat des benzodiaz\u00e9pines et m\u00e9dicaments apparent\u00e9s chez le patient \u00e2g\u00e9. Recommandation Professionnelles, pp. 4."},{"issue":"575","key":"10.1016\/j.euroneuro.2012.05.004_bib15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1192\/bjp.123.4.467","article-title":"The Set test as an aid to the detection of dementia in old people","volume":"123","author":"Isaacs","year":"1973","journal-title":"Br. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.euroneuro.2012.05.004_bib16","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/oxfordjournals.aje.a009137","article-title":"A 5-year longitudinal study of the Mini-Mental State Examination in normal aging","volume":"145","author":"Jacqmin-Gadda","year":"1997","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.euroneuro.2012.05.004_bib17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0895-4356(01)00453-X","article-title":"Benzodiazepine use and risk of dementia: a nested case-control study","volume":"55","author":"Lagnaoui","year":"2002","journal-title":"J. Clin. Epidemiol."},{"issue":"2","key":"10.1016\/j.euroneuro.2012.05.004_bib18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ageing\/afn277","article-title":"The risk of cognitive impairment in older community-dwelling women after benzodiazepine use","volume":"38","author":"Lagnaoui","year":"2009","journal-title":"Age Ageing"},{"issue":"4","key":"10.1016\/j.euroneuro.2012.05.004_bib19","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2307\/2529876","article-title":"Random-effects models for longitudinal data","volume":"38","author":"Laird","year":"1982","journal-title":"Biometrics"},{"issue":"3","key":"10.1016\/j.euroneuro.2012.05.004_bib20","first-page":"317","article-title":"Benzodiazepine use in the elderly: the EVA Study","volume":"51","author":"Lechevallier","year":"2003","journal-title":"Rev. Epidemiol. Sante Publique"},{"issue":"5","key":"10.1016\/j.euroneuro.2012.05.004_bib21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1517\/14740338.3.5.485","article-title":"Safety of benzodiazepines in the geriatric population","volume":"3","author":"Madhusoodanan","year":"2004","journal-title":"Expert Opin. Drug Saf."},{"issue":"6622","key":"10.1016\/j.euroneuro.2012.05.004_bib22","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.296.6622.601","article-title":"Prevalence, frequency, and duration of hypnotic drug use among the elderly living at home","volume":"296","author":"Morgan","year":"1988","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"issue":"7","key":"10.1016\/j.euroneuro.2012.05.004_bib23","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0895-4356(94)90170-8","article-title":"Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research","volume":"47","author":"Moride","year":"1994","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.euroneuro.2012.05.004_bib24","unstructured":"National Health Service Grampian, 2008. Guidance for prescribing and withrdawal of benzodiazepine and hypnotics in general practice, pp. 1."},{"issue":"9","key":"10.1016\/j.euroneuro.2012.05.004_bib25","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4088\/JCP.v63n0912","article-title":"Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom","volume":"63","author":"Ohayon","year":"2002","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.euroneuro.2012.05.004_bib26","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/gps.1023","article-title":"A systematic review of cognitive decline in the general elderly population","volume":"18","author":"Park","year":"2003","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"3","key":"10.1016\/j.euroneuro.2012.05.004_bib27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00004714-200206000-00009","article-title":"Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study","volume":"22","author":"Paterniti","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2012.05.004_bib28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/aje\/kwk017","article-title":"Sensitivity of four psychometric tests to measure cognitive changes in brain aging-population-based studies","volume":"165","author":"Proust-Lima","year":"2007","journal-title":"Am. J. Epidemiol."},{"issue":"3","key":"10.1016\/j.euroneuro.2012.05.004_bib29","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1037\/a0012838","article-title":"Gender and education impact on brain aging: a general cognitive factor approach","volume":"23","author":"Proust-Lima","year":"2008","journal-title":"Psychol. Aging"},{"key":"10.1016\/j.euroneuro.2012.05.004_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/aje\/kwr243","article-title":"Misuse of the Linear Mixed Model when evaluating risk factors of cognitive decline","author":"Proust-Lima","year":"2011","journal-title":"Am. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.euroneuro.2012.05.004_bib31","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1541-0420.2006.00573.x","article-title":"A nonlinear model with latent process for cognitive evolution using multivariate longitudinal data","volume":"62","author":"Proust","year":"2006","journal-title":"Biometrics"},{"key":"10.1016\/j.euroneuro.2012.05.004_bib32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","article-title":"Validity of the Trail Making Test as an indicator of organic brain damage","volume":"8","author":"Reitan","year":"1958","journal-title":"Percept. Mot. Skills"},{"issue":"6","key":"10.1016\/j.euroneuro.2012.05.004_bib33","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/01.wnl.0000266670.35219.0c","article-title":"The neuroprotective effects of caffeine: a prospective population study (the Three City Study)","volume":"69","author":"Ritchie","year":"2007","journal-title":"Neurology"},{"issue":"Suppl. 2","key":"10.1016\/j.euroneuro.2012.05.004_bib34","first-page":"9","article-title":"The effects of benzodiazepines on cognition","volume":"66","author":"Stewart","year":"2005","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.euroneuro.2012.05.004_bib35","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000072920","article-title":"Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population","volume":"22","author":"The 3C Study Group","year":"2003","journal-title":"Neuroepidemiology"},{"issue":"3","key":"10.1016\/j.euroneuro.2012.05.004_bib36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S0033291704003897","article-title":"Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies","volume":"35","author":"Verdoux","year":"2005","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.euroneuro.2012.05.004_bib37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000158226","article-title":"Evaluation of the impact of memantine treatment initiation on psychotropics use: a study from the French national health care database","volume":"31","author":"Vidal","year":"2008","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.euroneuro.2012.05.004_bib38","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology, 2000. Guidelines for ATC classification and DDD assignment. Oslo."},{"issue":"7","key":"10.1016\/j.euroneuro.2012.05.004_bib39","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/JGP.0b013e3181a65210","article-title":"The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data","volume":"17","author":"Wu","year":"2009","journal-title":"Am. J. Geriatr. Psychiatry"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X12001393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X12001393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T02:14:35Z","timestamp":1594260875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X12001393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0924977X12001393"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2012.05.004","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}